Searched for
DISHMAN PHARMACEUTICALS
Dishman Pharma Q2 net profit surges near two-fold to Rs 55 crConsolidated total income from operations also rose to Rs 436.55 crore for the quarter under review as against Rs 380.39 crore in the same ...- Buy Dishman Pharma, target Rs 260 : Rakesh BansalBuy Dishman Pharmaceuticals and Chemicals Ltd. at a price target of Rs 260 and a stoploss at Rs 220 from entry point
- Buy Dishman Pharmaceuticals & Chemicals Ltd., target Rs 222.0 : Ashish KyalBuy Dishman Pharmaceuticals & Chemicals Ltd. at a price target of Rs 222.0 and a stop loss at Rs 194.0 from entry point
- Dishman June quarter net climbs 14 per cent to Rs 46 croreNet sales, however, declined to Rs 365.9 crore during the June quarter as against Rs 400 crore a year earlier, Dishman Pharmaceuticals said...
- Buy Dishman Pharmaceuticals., target Rs 176: Kunal BothraBuy Dishman Pharmaceuticals & Chemicals Ltd. at a price target of Rs 176 and a stop loss at Rs 163.5
- Dishman Pharma shares up over 5% on board's nod for bonusShares of Dishman Pharmaceuticals and Chemicals surged over 5 per cent today after the company's board approved a bonus issue of equity sha...
- Dishman Pharmaceuticals Q3 net up two-fold to Rs 47 croreConsolidated total income of the company stood at Rs 388.73 crore for the quarter under consideration as against Rs 389.68 in the same peri...
- Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Buy Dishman Pharmaceuticals & Chemicals Ltd with a target of Rs 176: Ashwani Gujral'Dishman Pharmaceuticals & Chemicals Ltd is a ‘BUY’ call with a target of Rs 176 and a stop loss of Rs 162.'
- Buy Dishman Pharmaceuticals & Chemicals Ltd with a target of Rs 182: Mitesh Thacker'Dishman Pharmaceuticals & Chemicals Ltd is a 'BUY' call with a target of Rs 182 and a stop loss of Rs 160.'
- Buy Dishman Pharmaceuticals & Chemicals Ltd with target price of Rs 105: Mitesh Thacker"Dishman Pharmaceuticals & Chemicals Ltd is a ‘SELL’ call with a target of Rs 105 and a stop loss of Rs 94.50."
- Buy Dishman Pharmaceuticals & Chemicals Ltd with a target of Rs 55: Prakash Gaba"Dishman Pharmaceuticals & Chemicals Ltd is a ‘BUY’ call with a target of Rs 55 and a stop loss of Rs 48."
- Dishman Group appoints Mark Griffiths as CEODrug firm Dishman Pharmaceuticals and Chemicals today said Mark Griffiths has been appointed as Chief Executive Officer of Dishman Group of...
- Buy Dishman Pharmaceuticals as it can climb to 130 levels: Prakash GabaBuy Dishman Pharmaceuticals. Keep a stop somewhere below the levels of 120 and give a day or two. We should see it climb to levels closer t...
- Buy Dishman Pharmaceuticals with target of 127: Sandeep WagleBuy Dishman Pharmaceuticals & Chemicals with a target of Rs 127 and a stop loss of Rs 116.
- Buy Dishman Pharmaceuticals with a target of 95: Prakash GabaDishman Pharmaceuticals & Chemicals Ltd is a ‘BUY’ call with a target of Rs 95 and a stop loss of Rs 87.
- Dishman Pharmaceuticals Q3 net rises 10-foldDishman Pharmaceuticals and Chemicals today reported nearly 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quart...
- Dishman Pharma June quarter net dips 44.49 pc to Rs 15.12 crDishman Pharmaceuticals and Chemicals today said its consolidated net profit declined by 44.49 per cent to Rs 15.12 crore for the quarter e...
- Dishman ties up with California biotech coThe Rs 1,000-crore Dishman Pharmaceuticals, an Ahmedabad-based contract research and manufacturing services (CRAMS) major, has entered into...
- Dishman in pact with US-based CodexisThe Rs 1000-crore Dishman Pharmaceuticals, an Ahmedabad-based Contract Research and Manufacturing Services (CRAMS) major, has entered into ...
Load More
